LONGITUDE CAPITAL MANAGEMENT CO., LLC
LONGITUDE CAPITAL MANAGEMENT CO., LLC is a Series A, Series B and Series C+ fund in the US writing $1M–$30M checks into biotechnology, medical-technology and health-solutions.
- Stages
- Series A, Series B, Series C+
- Sectors
- biotechnology, medical-technology, health-solutions
- Check size
- $1M–$30M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2006
- Assets under management
- $2.08B
- Website
- longitudecapital.com
Thesis
Longitude Capital is a venture capital firm founded in 2006, with approximately $2.08 billion in assets under management across six funds. They specialize in venture growth investments within the biotechnology, medical technology, and health solutions sectors, targeting both private and public companies with clinically de-risked assets. Their strategy is opportunistic, encompassing spin-outs, recapitalizations, and PIPEs, and they typically lead or co-lead investments, seeking board seats. They leverage their industry network and proprietary research to identify transformative healthcare opportunities that improve clinical outcomes, enhance patient quality of life, and increase healthcare delivery efficiency. The firm has offices in Menlo Park, CA, and Boston, MA.
Common questions
Does LONGITUDE CAPITAL MANAGEMENT CO., LLC invest at the Series A stage?
Yes. LONGITUDE CAPITAL MANAGEMENT CO., LLC lists Series A, Series B and Series C+ among the stages it invests in.
What check size does LONGITUDE CAPITAL MANAGEMENT CO., LLC write?
LONGITUDE CAPITAL MANAGEMENT CO., LLC writes $1M–$30M checks.
Where does LONGITUDE CAPITAL MANAGEMENT CO., LLC invest?
LONGITUDE CAPITAL MANAGEMENT CO., LLC invests in the US.